Financial Astrology of MedImmune, Inc.

 

 

The Financial Astrology of MedImmune, Inc. is based on the astrology chart of MedImmune, Inc. We believe we can utilize Magi Astrology to forecast the major financial trends at MedImmune better than anyone who does not utilize Magi Astrology.

 

The astrology chart of MedImmune, Inc. is based on its date of incorporation. MedImmune, Inc. was most recently incorporated in Delaware as Molecular Vaccines Inc. on June 29, 1987.

 

The First Trade Date of MedImmune, Inc. stock is 05/08/1991. Many Financial Astrologers believe the First Trade Date is important in predicting the stock price. The Magi Society has built an online database of well over 7500 First Trade Dates. Anyone who purchases any version of our Financial Astrology Software is given access to this database. If you would like to know more about our Financial Astrology Software, please click here.


Financial Astrology Data: Important Information About MedImmune, Inc.

MedImmune is committed to advancing science to develop better medicines that help people live healthier, longer and more satisfying lives. It currently focuses its efforts on the areas of infectious disease, oncology and immunology. MedImmune markets four products: Synagis (palivizumab) and FluMist (Influenza Virus Vaccine Live, Intranasal) to help prevent two common respiratory infectious diseases; Ethyol (amifostine) to help reduce undesired side effects of certain anti-cancer chemo- and radiotherapies; and Cytogam (cytomegalovirus immune globulin intravenous (human)) to help prevent cytomegalovirus (CMV) disease associated with solid organ transplantation.

http://www.sec.gov/Archives/edgar/data/873591/000110465905010003/a05-2957_110k.htm#Item2_Properties_084711

---

 

 

 

IMPORTANT DISCLAIMER: By reading any of the material on this website you agree to our DISCLAIMER: The Magi Society, Magi Astrologers Worldwide Corporation make no claims whatsoever concerning the validity of the information provided herein, and will not be held liable for any use thereof. No information or opinion expressed here is a solicitation to buy or sell securities, bonds, real estate, commodities, options, futures or any financial instruments whatsoever.